Call for Abstract
15th International Pharmaceutical Microbiology and Biotechnology Conference, will be organized around the theme “To magnify the knowledge in the field of Microbiology and Biotechnology ”
Pharmaceutical Microbiology 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Pharmaceutical Microbiology 2017
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Antibiotics, also known as antibacterials, are a type of antimicrobial drug used in the treatment and prevention of bacterial infections. They can kill or inhibit the growth of bacteria. A limited number of antibiotics also possess antiprotozoal activity. Antibiotics are not effective against viruses such as colds or flu, and their inappropriate use allows the emergence of resistant organisms. In 1928, Alexander Fleming identified penicillin, the first chemical compound with antibiotic properties. Fleming was working on a culture of pathogenic bacteria when he noticed the spores of a small green mussel (Penicillium chrysogenum) in one of his culture plates. He observed that the presence of the mold killed or prevented the growth of bacteria.
The golden age of the discovery of antibiotics from 1940 to the early 1970s marked the beginning of a new era in human and animal health and the dramatic increase in human life expectancy. Indeed, the possibility of eradicating infectious diseases seemed possible. However, it soon became apparent that the microorganisms would not be defeated so easily. Their weapon: resistance to antibiotics. Today, resistance to microbial antibiotics rapidly depletes our supply of effective compounds and the possibility of a global public health disaster seems likely. The urgency of this situation has spawned a plethora of new multidisciplinary research initiatives in search of new antibiotics and other antimicrobial agents.
- Track 1-1Antibiotics, invention and innovation
- Track 1-2Medicine
- Track 1-3Neuropharmacology
- Track 1-4Pharmaceutical Health Sciences
- Track 1-5Medicinal Biochemistry
- Track 1-6Pharmaceutical Engineering
- Track 1-7Analytical Chemistry and Biophysics
- Track 1-8Medicinal Resources
- Track 1-9Bioorganic Chemistry
- Track 1-10Organic and Medicinal Chemistry
- Track 1-11Cellular Pharmacology
- Track 1-12Pharmaceutics
- Track 1-13Encouraging Antibiotic Innovation
- Track 1-14Antibiotic pipeline
- Track 1-15Molecular Microbiology
- Track 1-16New class of antibiotics discovered
- Track 1-17A Plan For New Antibiotics
- Track 1-18Pediatrics
- Track 1-19Clinical Pharmacodynamics
- Track 1-20Pharmacy Practice and Sciences
- Track 1-21Clinical Pharmacy
- Track 1-22Stem Cells
The study of macromolecules and macromolecular mechanisms that has an appearance in living organisms is called molecular biotechnology. The main objective of Molecular Biotechnology is to focus on the structure and function of the gene, the nature of the gene, gene replication, gene expressions and mutations. The concept of Molecular Biotechnology was introduced in the 1930s and 1940s and was not only imminent in the early stages of its introduction but gained importance in the 1950s and 1960s. The use of biotechnology Molecular was made by geneticists, structural chemists and physicists. Francis Crick introduced himself as a molecular biologist and further described as "a mixture of a crystallographer".
This implies more room for manufacture for different types of research and analysis. The different types of research involved are immunology, microbiology, genetics, cell biology and molecular biology. The importance of molecular biotechnology is becoming an imminent process in the field of agriculture. The main objective of Molecular Biotechnology is to understand the different biological processes involved and the creation of sensitive products.
- Track 2-1Translational Genomics
- Track 2-2Molecular Virology
- Track 2-3Molecular Cancer Genetics (LMCG)
- Track 2-4Computational Oncology
- Track 2-5RNA Biology and Biotechnology
- Track 2-6Biomarkers
- Track 2-7Synthetic and Structural Vaccinology
- Track 2-8Artificial Biology
- Track 2-9 Virus-Cell Interaction
- Track 2-10Computational Metagenomics
- Track 2-11Developmental Neurobiology
- Track 2-12Molecular Neuropathology
- Track 2-13Integrative biology
- Track 2-14Transcriptional neurobiology
- Track 2-15Molecular Biology
- Track 2-16Molecular and Microbial Genetics
- Track 2-17Microbes and medicine
- Track 2-18Applied and Environmental Microbiology
- Track 2-19Axonal neurobiology
- Track 2-20Neuro-Epigenetics
- Track 2-21Stem cells and regenerative medicine
- Track 2-22Molecular Medicine and Pathology
Medical biotechnology is the use of living cells and cellular materials for the research and production of pharmaceutical and diagnostic products that help to treat and prevent human diseases. Most medical biotechnologists work in academic or industrial settings. In university laboratories, these professionals conduct experiments in the framework of medical research studies; Industrial biotechnologists work on the development of drugs or vaccines. The field of medical biotechnology has made it possible to market microbial pesticides, insect resistant crops and environmental cleaning techniques.
Examples of discoveries in the field of medical biotechnology include insulin and growth hormone. The two discoveries were the result of research related to deoxyribonucleic acid (DNA). Many scientists in the field of medical biotechnology are studying genetic engineering. This involves the isolation, identification and sequencing of human genes to determine their functions. Working in this arena may eventually lead to remedies for certain diseases, such as Parkinson's disease and Alzheimer's syndrome.
- Track 3-1Infectious diseases
- Track 3-2Chronic diseases
- Track 3-3Vaccines and diagnostics
- Track 3-4Human genetics and genome analysis
- Track 3-5Stem cell research
- Track 3-6Regenerative medicine
- Track 3-7Biodesign
- Track 3-8Bioengineering
- Track 3-9Stem Cell Biology
Agents that is capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright, is known as anti-infective agent. Anti-infective is a general term that involves antifungals, antibiotics, anti-bacterial, anti-protozoans and antivirals.
The primary goal of final pharmaceutical product is Quality and Safety. Active Pharmaceutical Ingredients (API’s), used as ingredients in sterile medicinal products, must be sterile unless the final dosage form is terminally sterilized, or produced by a process including a sterilising filtration step. API’s intended for use in parenteral products must also comply with relevant specifications on bacterial endotoxins or pyrogens.
The manufacture of sterile API’s must be strictly controlled in order to reduce the risk of contamination with micro-organisms, endotoxins and particles. If the final dosage form is not to be sterilised by filtration, the API’s should be practically free of particles.
- Track 4-1Clinical research
- Track 4-2penicillins
- Track 4-3Antituberculosis agents
- Track 4-4Antimalarial agents
- Track 4-5Antifungals
- Track 4-6Anthelmintics
- Track 4-7Aminoglycosides
- Track 4-8Amebicides
- Track 4-9Anti-Infectives Drug Discovery
- Track 4-10Histoplasma capsulatum
In the areas of medicine, biotechnology and pharmacology, drug discovery is the process by which new drug candidates are discovered. Historically, drugs have been discovered by identifying the active ingredient from traditional remedies or by fortuitous discovery. Subsequent chemical libraries of small synthetic molecules, natural products or extracts have been screened in intact cells or whole organisms to identify substances that have a desirable therapeutic effect in a process known as conventional pharmacology. Since the sequencing of the human genome has allowed for the rapid cloning and synthesis of large amounts of purified proteins, it has become common to use high throughput screening of large compound libraries against isolated biological targets that are assumed to be a modification Of the disease in a process known as reverse pharmacology. The results of these screens are then tested in cells and then in animals for efficacy.
Drug development is the process of introducing a new pharmaceutical drug to the market once a lead compound has been identified by the drug discovery process. It includes pre-clinical research on micro-organisms and animals, the filing of regulatory status, such as through the US Food and Drug Administration for a new experimental drug to launch clinical trials on Humans and may include the step of getting regulatory approval with a new Drug to market the drug.
- Track 5-1Drug targets
- Track 5-2Screening and design
- Track 5-3Pharmaceutical drugs
- Track 5-4Clinical Research
- Track 5-5Clinical Trials
- Track 5-6Orphan Drugs
- Track 5-7 Pre-clinical research
Antibiotics are a type of antimicrobials that are used in treatment and prevention of bacterial infections. They may kill or inhibit the growth of bacteria. Many antibiotics are also effective against protozoans and fungi; some are toxic to humans and animals also, even when given in therapeutic dosage. Antibiotics are not effective against viruses such as common cold or influenza, and may be harmful when taken inappropriately. Physicians must ensure the patient has a bacterial infection before prescribing antibiotics. Antibiotic resistance invoke especially to the resistance to antibiotics that occurs in common bacteria that cause infection. The easy approach and capability of Antibiotics led to overuse in live-stock raising promotes bacteria to flourish resistance. This led to comprehensive problems with antibiotic resistance.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves outcomes for patients, reduces microbial resistance, and reduces the spread of infections caused by multidrug resistant organisms.
The abuse of antimicrobials is one of the most pressing public health problems in the world. Infectious organisms adapt to antimicrobials designed to kill them, making medicines ineffective. People infected with antimicrobial resistant organisms are more likely to have longer and more expensive hospital stays and may be more likely to die as a result of infection.
- Track 6-1Antimicrobials
- Track 6-2Research and development
- Track 6-3Antimicrobial Resistance & Infection Control
Biomedical engineering (BME) is the application of engineering principles and design concepts to medicine and biology for healthcare purposes (e.g. diagnostic or therapeutic). This field seeks to close the gap between engineering and medicine, combining the design and problem solving skills of engineering with medical and biological sciences to advance health care treatment, including diagnosis, monitoring, and therapy. Biomedical engineering has only recently emerged as its own study, compared to many other engineering fields. Such an evolution is common as a new field transitions from being an interdisciplinary specialization among already-established fields, to being considered a field in itself. Much of the work in biomedical engineering consists of research and development, spanning a broad array of subfields. Prominent biomedical engineering applications include the development of biocompatible prostheses, various diagnostic and therapeutic medical devices ranging from clinical equipment to micro-implants, common imaging equipment such as MRIs and EEGs, regenerative tissue growth, pharmaceutical drugs and therapeutic biological.
- Track 7-1 Biocompatible prostheses
- Track 7-2Clinical engineering
- Track 7-3Bionics
- Track 7-4Pharmaceutical engineering
- Track 7-5Neural engineering
- Track 7-6Genetic engineering
- Track 7-7Tissue engineering
- Track 7-8Biomedical optics
- Track 7-9Biomaterial
- Track 7-10Biomechanics
- Track 7-11Bioinformatics
- Track 7-12Therapeutic biologicals
- Track 7-13Pharmaceutical drugs
- Track 7-14Regenerative tissue growth
- Track 7-15 Medical devices
- Track 7-16Rehabilitation engineering
Clinical microbiology is a branch of medicine concerned with the prevention, diagnosis and treatment of infectious diseases caused by four kinds of microorganisms i.e. bacteria, fungi, parasites and viruses. In addition, this field of science studies various clinical applications of microbes for the improvement of health.
Rapid identification of microorganisms in the clinical microbiology laboratory can be of great value in selecting optimal patient management strategies for infections caused by bacteria, viruses, fungi, mycobacteria and parasites. Rapid identification of microorganisms in clinical specimens allows rapid de-escalation of broad spectrum agents to targeted antimicrobial therapy. Switching to appropriate therapy minimizes the risk of antibiotics, including disturbance of normal flora, toxic side effects and selective pressure. There is a critical need for new technologies in clinical microbiology, particularly for blood flow infections, the associated mortality among which is among the highest of all infections. It is equally important that the clinical laboratory community adopt laboratory experimental medicine practices and collaborate in translational research projects to establish clinical utility, cost-benefit and the impact of new technologies.
- Track 8-1Clinical Immunology
- Track 8-2Allergy
- Track 8-3Autoimmunity
- Track 8-4Cancer immunology and immunotherapy
- Track 8-5Inflammation
- Track 8-6Phagocytosis
- Track 8-7Immunotherapy and Vaccines
- Track 8-8Humoral Adaptive Immune System
- Track 8-9Immune System Development
- Track 8-10Transplantation
- Track 8-11Clonal Selection and Expansion
- Track 8-12Humoral Immune Effectors Functions
- Track 8-13Neutralization of antigen by secreted antibody
- Track 8-14Opsonization of Antigen
- Track 8-15Mucosal Immunity
- Track 8-16Antibody-dependent cell cytotoxicity (ADCC)
- Track 8-17Immediate hypersensitivity
- Track 8-18Neonatal Immunity
- Track 8-19Activation of the classical complement pathway
- Track 8-20Cell-mediated adaptive immune system
- Track 8-21Clinical Perspectives- Transplantation rejection
- Track 8-22Clinical Perspectives- Hypersensitivity
A biopharmaceutical product, also known as a biological (biological) or biological (biological) product, is any pharmaceutical drug product manufactured, extracted or semi-synthesized from biological sources. Different pharmaceutical products synthesized include vaccines, blood, blood components, allergens, somatic cells, gene therapies, tissues, recombinant therapeutic proteins and living cells used in cell therapy. Biological products can be composed of sugars, proteins or nucleic acids or complex combinations of these substances or may be living cells or tissues. They (or their precursors or components) are isolated from living sources - human, animal, plant, fungal or microbial.
The terminology surrounding biopharmaceuticals varies between groups and entities, with different terms referring to different subsets of therapeutics in the general biopharmaceutical category. Some regulators use the terms "biological drugs" or "therapeutic biologics" to refer specifically to macromolecular products manufactured such as protein and nucleic acid drugs, distinguishing them from products such as blood, blood components Or vaccines, Biological. Specialty drugs, a recent classification of pharmaceuticals, are high-priced drugs that are often biologics.
- Track 9-1Vaccines
- Track 9-2Generic drugs
- Track 9-3Biopharmaceutical Companies & Market Analysis
- Track 9-4Herbal Drug Interactions
- Track 9-5Interpenetrating Polymer Network as DDS
- Track 9-6Nanoparticles-An Innovative Drug Delivery System
- Track 9-7Protein Interactions as Targeted Therapeutics
- Track 9-8Regulatory Sciences
- Track 9-9Biowaiver
- Track 9-10Biological Medicine
- Track 9-11Biologic Drugs
- Track 9-12Array of Clinical Trials in Biopharmaceutics
- Track 9-13Applied Biopharmaceutics
- Track 9-14Xenobiotics
- Track 9-15recombinant DNA technology
- Track 9-16Biosimilars
- Track 9-17Gene therapy
- Track 9-18Biogenomic in emergency medicine
Cosmeceuticals refers to the combination of cosmetic and pharmaceutical products. Cosmeceuticals are cosmetic products with biologically active ingredients claiming to have medical or drug-like benefits.
Dermatological research suggests that the bioactive ingredients used in cosmeceuticals have benefits beyond the traditional moisturizer. However, despite reports of profits from some cosmeceutical products, there is no requirement to prove that these products live up to their claims.
The label "cosmeceutical" applies only to products applied locally, such as creams, lotions and ointments. Products that are similar in perceived benefits but ingested orally are known as nutricosmetics.
- Track 10-1Cosmetics and Pharmaceuticals
- Track 10-2Antioxidant
- Track 10-3 Clinical trials
Industrial and Microbial Biotechnology uses enzymes and micro-organisms to make bio based products in sectors such as chemicals, food and feed, detergents, paper and pulp, textiles and bioenergy (such as biofuels or biogas). In doing so, it uses renewable raw materials and is one of the most promising, innovative approaches towards lowering greenhouse gas emissions. The application of industrial biotechnology has been proven to make significant contributions towards mitigating the impacts of climate change in these and other sectors.
In addition to environmental benefits, biotechnology can improve industry’s performance and product value and, as the technology develops and matures, white biotechnology will yield more and more viable solutions for our environment. These innovative solutions bring added benefits for both our climate and our economy.
The rapid developments in biotechnology and the applications of genetic engineering to practical human problems have allowed the advancement of pharmaceutical biotechnology at a staggering pace. Furthermore, the release of the human genome sequence has also been key for the identification of human genetic diseases and the design of revolutionary approaches for their treatment.
Genetic engineering involves altering DNA molecules outside an organism, making the resultant DNA molecules function in living cells. Many of these cells have been genetically engineered to produce substances that are medically useful to humans.
Pharmaceutical biotechnology involves the use of living organisms such as microorganisms to create new pharmaceutical products, or safer and more effective versions of conventionally produced pharmaceuticals, more cost-effectively.
Since the manufacture of the first recombinant pharmaceutical, insulin, there has been a burst in the generation of new recombinant drugs, some of which will be covered later on in this chapter. Furthermore, the use of recombinant DNA technology has spread further allowing the development of not only subunit vaccines, such as the one used in the prevention of hepatitis B, but also attenuated vaccines vector vaccines and DNA vaccines. One of pharmaceutical biotechnology’s great potentials lies in gene therapy, which consists of the insertion of genetic material into cells to prevent, control or cure disease. It encompasses repairing or replacing defective genes and making tumours more susceptible to other kinds of treatment.
- Track 12-1Ruminant Nutrition
- Track 12-2Protein Engineering
- Track 12-3Biotechnology in Forensic Medicine
- Track 12-4Microarray Technology
- Track 12-5Clinical Research/Clinical Trials
- Track 12-6Personalized Medicine
- Track 12-7Biomarkers
- Track 12-8Biopharmaceutical Manufacturing and Diagnostics
- Track 12-9Downstream Processing of Biopharmaceuticals
- Track 12-10Technological and Clinical Aspects of Biopharmaceuticals
- Track 12-11Biopharmaceuticals Discovery
- Track 12-12Vaccines and Antibiotics
- Track 12-13Bioinformatics
Healthcare biotechnology refers to a medicinal or diagnostic product or a vaccine that consists of, or has been produced in, living organisms and may be manufactured via recombinant technology (recombinant DNA is a form of DNA that does not exist naturally. It is created by combining DNA sequences that would not normally occur together). This technology has a tremendous impact on meeting the needs of patients and their families as it not only encompasses medicines and diagnostics that are manufactured using a biotechnological process, but also gene and cell therapies and tissue engineered products. Biotechnology offers patients a variety of new solutions such as: Unique, targeted and personalized therapeutic and diagnostic solutions for particular diseases or illnesses, An unlimited amount of potentially safer products, Superior therapeutic and diagnostic approaches, Higher clinical effectiveness because of the biological basis of the disease being known, Development of vaccines for immunity, Treatment of diseases, Cultured Stem Cells and Bone Marrow Transplantation, Skin related ailments and use of cultured cell, Genetic Counseling, Forensic Medicine, Gene Probes, Genetic Fingerprinting, Karyotyping.
Biomanufacturing is a type of manufacturing or biotechnology that uses biological systems to produce biomaterials and biomolecules that are commercially important for drugs, food and beverage processing, and industrial applications. Organically produced products are recovered from natural sources, such as blood, or cultures of microbes, animal cells or plant cells grown in specialized equipment. The cells used during production may have been naturally produced or derivatives using genetic engineering techniques.
- Track 14-1Bio-fuels
- Track 14-2Energy Crops (cellulosic ethanol industry)
- Track 14-3Industrial Enzymes
- Track 14-4Bioprocess Engineering and Optimization
Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". This field holds the promise of engineering damaged tissues and organs by stimulating the body's own repair mechanisms to functionally heal previously irreparable tissues or organs.
Regenerative medicine also includes the possibility of growing tissues and organs in the laboratory and implanting them when the body cannot heal itself. If a regenerated organ's cells would be derived from the patient's own tissue or cells, this would potentially solve the problem of the shortage of organs available for donation, and the problem of organ transplant rejection.
Some of the biomedical approaches within the field of regenerative medicine may involve the use of stem cells. Examples include the injection of stem cells or progenitor cells obtained through directed differentiation (cell therapies); the induction of regeneration by biologically active molecules administered alone or as a secretion by infused cells (immunomodulation therapy); and transplantation of in vitro grown organs and tissues (tissue engineering).
- Track 15-1Stem Cells
- Track 15-2Gene Therapy
- Track 15-3Cell Based Therapy
- Track 15-4Tissue Engineering
- Track 15-5Cell Cultivation
- Track 15-6Clinical Research/Clinical trials
A biofuel is a fuel that is produced by contemporary biological processes, such as agriculture and anaerobic digestion, rather than a fuel produced by geological processes such as those involved in the formation of fossil fuels such as coal and Oil, from prehistoric biological material. Biofuels can come directly from plants, or indirectly from agricultural, commercial, domestic and / or industrial wastes. Renewable biofuels typically involve the fixation of contemporary carbon, such as those that occur in plants or microalgae through the process of photosynthesis. Other renewable biofuels are made from the use or conversion of biomass (referring to living organisms recently, most often referring to plants or plant-derived materials). This biomass can be converted into suitable energy substances in three different ways: thermal conversion, chemical conversion and biochemical conversion. This conversion of the biomass can result in a fuel in solid, liquid or gaseous form. This new biomass can also be used directly for biofuels.
Bioethanol is an alcohol obtained by fermentation, mainly from carbohydrates produced in sugar or starch cultures such as corn, sugar cane or sweet sorghum. Cellulosic biomass, derived from non-food sources, such as trees and grasses, is also developed as a raw material for ethanol production. Ethanol can be used as fuel for vehicles in its pure form, but it is usually used as an additive to increase octane and improve vehicle emissions. Bioethanol is widely used in the United States and Brazil. The current design of the facility does not convert the lignin portion of the plant raw materials into fuel components by fermentation.
Biodiesel can be used as a fuel for vehicles in its pure form, but is usually used as a diesel additive to reduce the levels of particulate matter, carbon monoxide and hydrocarbons in diesel vehicles. Biodiesel is produced from oils or fats by trans esterification and is the most common biofuel in Europe.
Biosafety is the prevention of large-scale loss of biological integrity, focusing both on ecology and human health. These prevention mechanisms include conduction of regular reviews of the biosafety in laboratory settings, as well as strict guidelines to follow. Biosafety is used to protect from harmful incidents. Many laboratories handling biohazards employ an on-going risk management assessment and enforcement process for biosafety. Failures to follow such protocols can lead to increased risk of exposure to biohazards or pathogens. Human error and poor technique contribute to unnecessary exposure and compromise the best safeguards set into place for protection.
Biosafety in agriculture, chemistry, medicine, exobiology and beyond will likely require the application of the precautionary principle, and a new definition focused on the biological nature of the threatened organism rather than the nature of the threat.
Bioethics is the study of the typically controversial ethical issues emerging from new situations and possibilities brought about by advances in biology and medicine. It is also moral discernment as it relates to medical policy and practice. Bioethicists are concerned with the ethical questions that arise in the relationships among life sciences, biotechnology, medicine, politics, law, and philosophy. It also includes the study of the more commonplace questions of values ("the ethics of the ordinary") which arise in primary care and other branches of medicine.
- Track 17-1Biosafety Regulations
- Track 17-2Intellectual Property Rights
- Track 17-3Ethical Issues of Human Genome Project
- Track 17-4Organs Transplantation and Stem Cell Research
- Track 17-5Handling and Disposal of Hazardous Materials
This session will provide the opportunity to hear “both sides of the story” from a non-sterile aqueous product contamination case. Speakers will present both industry and FDA perspectives from an actual product contamination event, and the path taken to resolve the problem. Attendees will discover how FDA and industry worked together to solve a microbial product issue, and the lessons learned from the case.
- Track 18-1Factors affecting choice of antimicrobial agent
- Track 18-2Properties of the chemical agent
- Track 18-3Mycobacterium tuberculosis
- Track 18-4Vegetative bacteria
- Track 18-5 Bacterial spores
- Track 18-6Toxicity of the agent
- Track 18-7Acids and esters
- Track 18-8Benzoic acid
- Track 18-9Sorbic acid
- Track 18-10Sulphur dioxide, sulphites and metabisulphites
- Track 18-11Esters of p-hydroxybenzoic acid (parabens)
- Track 18-12Alcohols used for disinfection and antisepsis
- Track 18-13Alcohols as preservatives
- Track 18-14Aldehydes
- Track 18-15Glutaraldehyde
- Track 18-16Ortho-phthalaldehyde
- Track 18-17Formaldehyde
- Track 18-18Formaldehyde-releasing agents
- Track 18-19Chlorhexidine and alexidine
- Track 18-20Polyhexamethylene biguanides
- Track 18-21Halogens
- Track 18-22Hypochlorites
- Track 18-23Organic chlorine compounds
- Track 18-24Chloroform
- Track 18-25Iodine
- Track 18-26Iodophors
- Track 18-27Heavy metals
- Track 18-28Mercurials
- Track 18-29Hydrogen peroxide and peroxygen compounds
- Track 18-30Phenols
- Track 18-31Phenol (carbolic acid)
- Track 18-32 Clear soluble fluids, black fluids and white fluids
- Track 18-33Synthetic phenols
- Track 18-34 Bisphenols
- Track 18-35 Surface-active agents
- Track 18-36Cationic surface-active agents
- Track 18-37Diamidines
- Track 18-38Dyes
- Track 18-39Quinoline derivatives
- Track 18-40Antimicrobial combinations and systems
- Track 18-41Disinfection policies
Due to multidisciplinary nature of the field of biotechnology, a wide range of different branches of science have made significant contributions to the fast development of this field. Some of these discipline are- biochemical engineering, physiology, biochemistry, food science, material science, bioinformatics, immunology, molecular biology, chemical engineering etc. Biotechnology is also improving the lives of people around the world. Biotechnology also has affected economy in a positive way due to the creation and growth of small business, generation of new jobs. Agricultural biotechnology has reduced our dependency on pesticides. Bioremediation technologies are being used to clean our environment by removing toxic substances from contaminated ground water and soils. about 60% of the biotechnology products in the market are healthcare products and 21% are products used in agriculture and animal husbandry. A considerable amount of efforts in research are on, to use and extract benefit from this interesting and upcoming field for the betterment of human life and the environment. Many biochemical companies are involved in the production of biotechnological products using genetic engineering techniques
- Track 19-1Ruminant Nutrition
- Track 19-2Cancer therapy by Immunogenic Oligopeptide
- Track 19-3Reproductive Medicine
- Track 19-4Urology
- Track 19-5Biotechnology for Biofuels
- Track 19-6Nutritional approach vs Alzheimer’s disease
- Track 20-1Strategic Alliances
- Track 20-2Venture Capital and Financing
- Track 20-3Outsourcing
- Track 20-4Merger and Acquisitions
- Track 20-5Licensing
- Track 20-6Growth
- Track 20-7Business Models and Strategies
- Track 20-8Product Opportunities
- Track 20-9Partnering Trends
- Track 20-10Intellectual Property